Data / Form D filings / TNF Pharmaceuticals, Inc.
TNF Pharmaceuticals, Inc.: Form D filings
TNF Pharmaceuticals, Inc., a pharmaceuticals company in New York, NY, filed 10 Form D notices with the SEC between 2017 and 2025. The latest, on September 5, 2025, reports $7 million sold of a $7 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, New York, NY, 10036
- Phone
- (856) 848-8698
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1321834
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | New notice | $7,000,000 | $7,000,000 | 12 | Sep 2, 2025 | sec.gov | |
| May 31, 2024 | New notice | $15,150,007 | $15,150,007 | 5 | May 20, 2024 | sec.gov | |
| May 31, 2024 | New notice | $26,850,006 | $26,850,006 | 4 | May 20, 2024 | sec.gov | |
| Aug 30, 2022 | New notice | $7,411,761 | $0 | $7,411,761 | 8 | Aug 15, 2022 | sec.gov |
| Nov 24, 2020 | New notice | $18,067,000 | $18,067,000 | 56 | Nov 11, 2020 | sec.gov | |
| Aug 11, 2020 | New notice | Indefinite | $0 | 1 | Aug 3, 2020 | sec.gov | |
| May 21, 2020 | New notice | $482,498 | $482,498 | 4 | May 18, 2020 | sec.gov | |
| Apr 14, 2020 | New notice | $459,998 | $459,998 | 1 | Apr 8, 2020 | sec.gov | |
| Apr 7, 2020 | New notice | $2,718,057 | $1,233,057 | $1,485,000 | 4 | Mar 23, 2020 | sec.gov |
| Apr 13, 2017 | New notice | $2,027,760 | $2,027,760 | 4 | Mar 30, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Schreiber | Director | |
| Bruce Bernstein | Director | |
| Ian Rhodes | Executive Officer | |
| Mitchell J. Glass | Executive Officer, Director | |
| Stephen J. Friscia | Director | |
| Bill J. White | Director | |
| Joshua Silverman | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Sep 1, 2025 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TNF Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.